Elevai Labs Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a pioneering force in medical aesthetics, today reported financial results for the third quarter ended September 30, 2024 and provided a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback